Skip to main content
. 2020 Jul 2;15(7):e0235202. doi: 10.1371/journal.pone.0235202

Table 6. Histopathological results among non-attendees* (intention to treat).

Telephone group Pap Smear N = 36 Telephone Group HPV self-Sampling test N = 12 HPV self-sampling–test group N = 57 Summary Non-attendees with intervention N = 105 Control group N = 14 OR (95% conf. interval)
Benign 13 7 14 34 3 Ref 1
LSIL 8 2 24 34 5 0.6 (0.08–3.4)
HSIL 9 2 13 24 5 0.4 (0.06–2.4)
AIS** 1 1
SCC 5 5 10 1 0.9 (0.06–51)
Adeno carcinoma 1 1
Unspecified 1 1

*Until 31 December 2017

** Adenocarcinoma in situ